
Thursday 7 July 2022
08.30 Registration
08.55 Welcome
Jon Green, One Nucleus
09.00 Keynote Presentation
Melanie Lee, LifeArc
09.20 Enabling Bio Innovation
A Keynote presentation and panel to discuss the main technology, human and societal drivers of successful bio innovation.
Chair: Priya Kalia, SciTribe
David Joyce, Thermo Fisher
Michael Chen, Nuclera
Jeroen Verheyen, Semarion
Paul Smith, BC Platforms
10.20 Coffee Break
10.50 Bio Innovation in Therapeutics – AI Discovered Drugs in Action
With the first ‘AI discovered’ drugs starting to be approved, our expert panel will discuss how much this game changing technology will impact development life cycles and who may be the biggest winners from its deployment.
Chair: Julia Gwilt, Appleyard Lees
Pascal Savy, Charles River
James Dale, Pharmenable
Rabia Khan, Ladder Therapeutics
11.40 Bio Innovation in Diagnostics – From Population to Precision
A panel discussion to highlight how the technology developments in omics, biomarkers identification and data collection are shifting the value proposition for diagnostics.
Chair: James Evans, EY
Jenny Barnett, Monument Therapeutics
Santiago Miriuka, MultiplAI Health
Debora Lucarelli, Enhanc3D Genomics
Alison Howie, DNAe
12.30 Lunch
13.30 Bio Innovation in Prevention – the Good, the Bad and the Bugly
After two years focusing mostly on one virus, many innovations in the space of AMR, microbiome or general surveillance were overlooked. This panel will discuss the opportunities now arising in a more holistic approach to human – ‘bug’ interaction.
Chair: Richard Vickers, tranScrip
Anne Neville, Microbiotica
Michel de Baar, MSD
Mike Whelan, CEPI
Martin Stocks, Iceni Glyoscience
14.20 Bio Innovation in Development – Manufacturing Cell and Gene Therapeutics
The panel will discuss key technology advances in manufacture of cell and gene therapies, a crucial topic for those developing therapeutics who hope they will become market leaders.
Chair: Adrian Toutoungi, Taylor Wessing
Angela Osborne, eXmoor Pharma Concepts
Kerstin Papenfuss, Deep Science Ventures
Julie Wood, Thermo Fisher Scientific
Steven Howe, GSK
15.10 Coffee Break
15.45 Keynote Presentation – US Perspective of the Cambridge Life Science Ecosystem
Tim Schoen, BioMed Realty
15.55 Back to the Future – Reinventing Bio Innovation Ecosystems
A presentation and panel reflecting on the key ingredients that create the most successful Bio Innovation Ecosystems and how they must evolve to keep pace with the fast-moving world we live in.
Chair: Mike Ward, Clarivate
Andy Neely, University of Cambridge
Tim Schoen, BioMed Realty
Belinda Clarke, Agri-TechE
James Fry, Mills & Reeve
Wael Muselmani, MedCity
16.55 Closing Remarks
17.00 Drinks Reception
18.30 End
Headline Sponsor
Sponsors
Media Supporters
Event Supporters